- Home
- GIII vs EWTX Comparison
GIII vs EWTX Comparison
Compare GIII & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIII
- EWTX
- Stock Information
- Founded
- GIII 1956
- EWTX 2017
- Country
- GIII United States
- EWTX United States
- Employees
- GIII N/A
- EWTX 117
- Industry
- GIII Apparel
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- GIII Consumer Discretionary
- EWTX Health Care
- Exchange
- GIII Nasdaq
- EWTX Nasdaq
- Market Cap
- GIII 1.2B
- EWTX 1.5B
- IPO Year
- GIII 1989
- EWTX 2021
- Fundamental
- Price
- GIII $23.36
- EWTX $13.01
- Analyst Decision
- GIII Buy
- EWTX Buy
- Analyst Count
- GIII 6
- EWTX 9
- Target Price
- GIII $28.83
- EWTX $39.89
- AVG Volume (30 Days)
- GIII 1.1M
- EWTX 936.5K
- Earning Date
- GIII 06-06-2025
- EWTX 08-07-2025
- Dividend Yield
- GIII N/A
- EWTX N/A
- EPS Growth
- GIII 12.17
- EWTX N/A
- EPS
- GIII 4.28
- EWTX N/A
- Revenue
- GIII $3,154,658,000.00
- EWTX N/A
- Revenue This Year
- GIII $0.32
- EWTX N/A
- Revenue Next Year
- GIII N/A
- EWTX N/A
- P/E Ratio
- GIII $5.43
- EWTX N/A
- Revenue Growth
- GIII 1.72
- EWTX N/A
- 52 Week Low
- GIII $20.33
- EWTX $10.60
- 52 Week High
- GIII $36.18
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- GIII 48.10
- EWTX 35.24
- Support Level
- GIII $22.26
- EWTX $12.72
- Resistance Level
- GIII $22.94
- EWTX $13.84
- Average True Range (ATR)
- GIII 0.82
- EWTX 0.67
- MACD
- GIII 0.28
- EWTX -0.18
- Stochastic Oscillator
- GIII 85.07
- EWTX 24.36
About GIII G-III Apparel Group LTD.
G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.